Hemophilia Clinical Trials
165 clinical trials for Hemophilia across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B — RECRUITING · PHASE1
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) — RECRUITING
- An open-label, parallel, Phase 3, two-arm study to investigate the efficacy and safety of fitusiran
prophylaxis in male participants aged 1 to less than 12 years with hemophilia A or B with or without inhibitory antibodies to Factors VIII or IX — RECRUITING · PHASE3
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders — RECRUITING
- Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain — RECRUITING · NA
- A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B — RECRUITING · PHASE3
- Effects of Photobiomodulation in Hemophilia Patients. — RECRUITING · NA
- Adult and Adolescent Hemophilia Patients Treated With Marstacimab: a Patient Experience Registry — RECRUITING
- ATHNdataset Registry — RECRUITING
- Monitoring of Anti-TFPI in Hemophilia — RECRUITING
- PCC Treatment for Hemophilia Patients With Inhibitor(2022PCC-A) — RECRUITING · PHASE4
- National Longitudinal Cohort of Hematological Diseases — RECRUITING
- Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia — RECRUITING · NA
- High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT) — RECRUITING
- Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors — RECRUITING
- Patient Reported Outcomes Burdens and Experiences - Phase 3 — RECRUITING
- Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia — RECRUITING
- Comparison of Upper Extremity Functional Performance in Hemophilic and Healthy Children — RECRUITING
- Trial of an Exercise Intervention for Children With Haemophilia — RECRUITING · NA
- Embolization in Hereditary Coagulopathies — RECRUITING · NA
- AN OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY, TOLERABILITY, AND EFFICACY OF MARSTACIMAB PROPHYLAXIS IN SEVERE (COAGULATION FACTOR ACTIVITY <1%) HEMOPHILIA A PARTICIPANTS WITH OR WITHOUT INHIBITORS OR MODERATELY SEVERE TO SEVERE HEMOPHILIA B PARTICIPANTS (COAGULATION FACTOR ACTIVITY <=2%) WITH OR WITHOUT INHIBITORS — RECRUITING
- A PHASE IIIB, MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF SUBCUTANEOUS EMICIZUMAB IN PATIENTS FROM BIRTH TO 12 MONTHS OF AGE WITH HEMOPHILIA A WITHOUT INHIBITORS — RECRUITING · PHASE3
- ATLAS-OLE: AN OPEN-LABEL, LONG-TERM SAFETY AND EFFICACY STUDY OF FITUSIRAN IN PATIENTS WITH HEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORY ANTIBODIES TO FACTOR VIII OR IX — RECRUITING
- A MULTICENTER, OPEN LABEL STUDY TO EVALUATE THE SAFETY, EFFICACY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF EMICIZUMAB IN PATIENTS WITH MILD OR MODERATE HEMOPHILIA A WITHOUT FVIII INHIBITORS. — RECRUITING
- ATLAS-PEDS: AN OPEN-LABEL, MULTINATIONAL STUDY OF FITUSIRAN PROPHYLAXIS IN MALE PEDIATRIC SUBJECTS AGED 1 TO LESS THAN 12 YEARS WITH HEMOPHILIA A OR B. — RECRUITING
- Implementation of pharmacokinetic-guided dosing of prophylaxis in hemophilia patients. — ACTIVE_NOT_RECRUITING · PHASE4
- Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients — ACTIVE_NOT_RECRUITING · PHASE3
- Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults With Hemophilia and Hemophilic Arthropathy — COMPLETED
- Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery — TERMINATED · PHASE3
- Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study — WITHDRAWN · PHASE1
- Effect of Non-Surgical Periodontal Treatment on Oral Health in Hemophilia Patients — COMPLETED · NA
- Intra-Articular Bevacizumab for Preventing Recurrent Hemarthrosis in Hemophilia With Chronic Synovitis — COMPLETED · NA
- Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B — ACTIVE_NOT_RECRUITING · PHASE2
- Haemophilia and Bone Loss - PHILEOS Study — COMPLETED · NA
- Chronic Pain and Hemophilia — ACTIVE_NOT_RECRUITING
- Effectiveness of an Adapted Physical Activity Program for Subjects Suffering From Haemophilia — COMPLETED · NA
- Low-Cost Platelet-Rich Plasma for Hemarthropathy — COMPLETED · NA
- ATLAS-PEDS: An open-label, multinational study of fitusiran prophylaxis in pediatric subjects ages 1 to less than 12 years with hemophilia A or B — TERMINATED · PHASE3
- A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis — ACTIVE_NOT_RECRUITING · PHASE4
- Canadian CHO-KLAT/H-FIT Study - Quality of Life of, and Burden of Caring for, Persons With Hemophilia — COMPLETED
- Evaluation of clinical and functional parameters in patients with Hemophilia aged above 60 years — OTHER
- Blood Flow Restriction in Improving Muscle Strength of Patients With Hemophilic Ankle Arthropathy — COMPLETED · NA
- EPOCH-Economics and Patient Outcomes in China in Haemophilia — ACTIVE_NOT_RECRUITING
- 3D Ultrasound in Hemophilic Ankles — NOT_YET_RECRUITING · NA
- Validity and Reliability of the Two-minute Step Test in Hemophilia — NOT_YET_RECRUITING
- Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy — NOT_YET_RECRUITING · NA
- Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Receiving Prophylactic Treatment With Emicizumab — NOT_YET_RECRUITING
- Central Sensitisation in Patients With Haemophilia and Degenerative Arthropathy — COMPLETED
- A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia — ACTIVE_NOT_RECRUITING · PHASE3
- Resistance Training With Blood Flow Restriction in Hemophilia — COMPLETED · NA
Refine this search